Abbott Laboratories, a blue chip firm with a market capitalization of more than $200 billion and a track record of delivering share price growth, has very bullish growth estimates for 2021 based on COVID testing. Continue reading
Abbott Laboratories, a blue chip firm with a market capitalization of more than $200 billion and a track record of delivering share price growth, has very bullish growth estimates for 2021 based on COVID testing. Continue reading
